| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $217K | -1.8% | — |
| R&D Expense | $26.8M | +3.6% | -14.2% |
| SG&A Expense | $11.9M | -15.0% | -32.7% |
| Operating Income | -$38.5M | +2.9% | +21.3% |
| Interest Expense | $2K | +100.0% | +0.0% |
| Pre-tax Income | -$35.3M | +2.3% | +18.7% |
| Income Tax | $560K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $95.3M | +12.2% | -11.8% |
| Current Assets | $300.0M | -7.5% | -30.3% |
| Total Assets | $351.6M | -5.5% | -25.9% |
| Current Liabilities | $29.1M | +2.8% | +15.4% |
| Total Liabilities | $33.3M | +1.8% | +6.2% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$87.6M | — | — |
| Capital Expenditures | $9.4M | — | — |
| Investing Cash Flow | $75.9M | — | — |
| Financing Cash Flow | $7.9M | — | — |
| Free Cash Flow | -$97.0M | — | — |
| -34.0% |
| +123.9% |
| Net Income | -$16.5M | +0.5% | +8.0% |
| -$1.01B |
| -0.6% |
| -2.9% |